stem cells treated with the anti-b7 antibodies
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00475384)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- Tumor antigensImmunity, passive
immunity, passive - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- stem cells treated with the anti-b7 antibodies
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00475384 | Phase 1 | Jun 1, 2006 | Harvard University, National Cancer Institute (NCI), University of Texas at Houston |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2006 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1